These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 25286244)

  • 21. Cross-Regulation of F-Box Protein FBXL2 with T-bet and TNF-α during Acute and Chronic Lung Allograft Rejection.
    Das A; Wang X; Wei J; Hoji A; Coon TA; Popescu I; Brown M; Frizzell S; Iasella CJ; Noda K; Sembrat JC; Devonshire K; Hannan SJ; Snyder ME; Pilewski JM; Sanchez PG; Chandra D; Mallampalli RK; Alder JK; Chen BB; McDyer JF
    J Immunol; 2022 Nov; 209(9):1788-1795. PubMed ID: 36113884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection.
    Shimizu K; Libby P; Rocha VZ; Folco EJ; Shubiki R; Grabie N; Jang S; Lichtman AH; Shimizu A; Hogg N; Simon DI; Mitchell RN; Croce K
    Circulation; 2011 Dec; 124(25):2920-32. PubMed ID: 22144572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights in CD28-independent allograft rejection.
    Habicht A; Najafian N; Yagita H; Sayegh MH; Clarkson MR
    Am J Transplant; 2007 Aug; 7(8):1917-26. PubMed ID: 17617854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-5 and eosinophils mediate the rejection of fully histoincompatible vascularized cardiac allografts: regulatory role of alloreactive CD8(+) T lymphocytes and IFN-gamma.
    Braun MY; Desalle F; Le Moine A; Pretolani M; Matthys P; Kiss R; Goldman M
    Eur J Immunol; 2000 May; 30(5):1290-6. PubMed ID: 10820374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-mobility group box 1 promotes early acute allograft rejection by enhancing IL-6-dependent Th17 alloreactive response.
    Duan L; Wang CY; Chen J; Gong Q; Zhu P; Zheng F; Tan Z; Gong F; Fang M
    Lab Invest; 2011 Jan; 91(1):43-53. PubMed ID: 20714327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective CD8 Signaling Pathways Delay Rejection in Older Recipients.
    Bedi DS; Krenzien F; Quante M; Uehara H; Edtinger K; Liu G; Denecke C; Jurisch A; Kim I; Li H; Yuan X; Ge X; ElKhal A; Tullius SG
    Transplantation; 2016 Jan; 100(1):69-79. PubMed ID: 26356176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-17 promotes early allograft inflammation.
    Gorbacheva V; Fan R; Li X; Valujskikh A
    Am J Pathol; 2010 Sep; 177(3):1265-73. PubMed ID: 20651239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
    Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical role of CD4 help in CD154 blockade-resistant memory CD8 T cell activation and allograft rejection in sensitized recipients.
    Wu Z; Wang Y; Gao F; Shen X; Zhai Y; Kupiec-Weglinski JW
    J Immunol; 2008 Jul; 181(2):1096-102. PubMed ID: 18606661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
    Zhai Y; Meng L; Gao F; Busuttil RW; Kupiec-Weglinski JW
    J Immunol; 2002 Oct; 169(8):4667-73. PubMed ID: 12370407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation.
    Medoff BD; Seung E; Wain JC; Means TK; Campanella GS; Islam SA; Thomas SY; Ginns LC; Grabie N; Lichtman AH; Tager AM; Luster AD
    J Exp Med; 2005 Jul; 202(1):97-110. PubMed ID: 15998790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients.
    Nozaki T; Amano H; Bickerstaff A; Orosz CG; Novick AC; Tanabe K; Fairchild RL
    J Immunol; 2007 Oct; 179(8):5238-45. PubMed ID: 17911609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-17 deficiency attenuates allograft injury and prolongs survival in a murine model of fully MHC-mismatched renal allograft transplantation.
    Kwan T; Chadban SJ; Ma J; Bao S; Alexander SI; Wu H
    Am J Transplant; 2015 Jun; 15(6):1555-67. PubMed ID: 25824574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
    Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease.
    Mauermann N; Burian J; von Garnier C; Dirnhofer S; Germano D; Schuett C; Tamm M; Bingisser R; Eriksson U; Hunziker L
    Am J Respir Crit Care Med; 2008 Aug; 178(4):379-88. PubMed ID: 18511701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.
    Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN
    Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-1 Receptor Signaling on Graft Parenchymal Cells Regulates Memory and De Novo Donor-Reactive CD8 T Cell Responses to Cardiac Allografts.
    Iida S; Tsuda H; Tanaka T; Kish DD; Abe T; Su CA; Abe R; Tanabe K; Valujskikh A; Baldwin WM; Fairchild RL
    J Immunol; 2016 Mar; 196(6):2827-37. PubMed ID: 26856697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD8+ T cell subsets TC1 and TC2 cause different histopathologic forms of murine cardiac allograft rejection.
    Delfs MW; Furukawa Y; Mitchell RN; Lichtman AH
    Transplantation; 2001 Mar; 71(5):606-10. PubMed ID: 11292288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tim-1-Fc suppresses chronic cardiac allograft rejection and vasculopathy by reducing IL-17 production.
    Shi X; Zhang M; Liu F; Wang Z; Zhang L; Cheng H; Zhang S; Fei T; Guo M; Bian J; Wang Q; Ding G
    Int J Clin Exp Pathol; 2014; 7(2):509-20. PubMed ID: 24551271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection.
    El-Sawy T; Belperio JA; Strieter RM; Remick DG; Fairchild RL
    Circulation; 2005 Jul; 112(3):320-31. PubMed ID: 15998678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.